| Topical application of a peptide inhibitor of transforming growth factor-β1 ameliorates bleomycin-induced skin fibrosis B Santiago, I Gutierrez-Cañas, J Dotor, G Palao, JJ Lasarte, J Ruiz, ... Journal of Investigative Dermatology 125 (3), 450-455, 2005 | 200 | 2005 |
| Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis Y Juarranz, C Abad, C Martinez, A Arranz, I Gutierrez-Cañas, F Rosignoli, ... Arthritis research & therapy 7, 1-12, 2005 | 159 | 2005 |
| VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts I Gutierrez-Canas, Y Juarranz, B Santiago, A Arranz, C Martinez, ... Rheumatology 45 (5), 527-532, 2006 | 105 | 2006 |
| Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells MG Juarranz, B Santiago, M Torroba, I Gutierrez-Canas, G Palao, ... Rheumatology 43 (4), 416-422, 2004 | 103 | 2004 |
| IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts M Carrion, Y Juarranz, C Martínez, I Gonzalez-Alvaro, JL Pablos, ... Rheumatology 52 (12), 2177-2186, 2013 | 90 | 2013 |
| CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans B Santiago, F Baleux, G Palao, I Gutiérrez-Cañas, JC Ramírez, ... Arthritis research & therapy 8, 1-8, 2006 | 90 | 2006 |
| Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts Y Juarranz, I Gutiérrez‐Cañas, B Santiago, M Carrión, JL Pablos, ... Arthritis & Rheumatism 58 (4), 1086-1095, 2008 | 86 | 2008 |
| RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide M Carrión, Y Juarranz, S Pérez‐García, R Jimeno, JL Pablos, RP Gomariz, ... Arthritis & Rheumatism 63 (6), 1626-1636, 2011 | 79 | 2011 |
| VIP and PACAP are autocrine factors that protect the androgen‐independent prostate cancer cell line PC‐3 from apoptosis induced by serum withdrawal I Gutiérrez‐Cañas, N Rodríguez‐Henche, O Bolaños, MJ Carmena, ... British journal of pharmacology 139 (5), 1050-1058, 2003 | 71 | 2003 |
| New insights into the role of VIP on the ratio of T‐cell subsets during the development of autoimmune diabetes R Jimeno, RP Gomariz, I Gutiérrez‐Cañas, C Martínez, Y Juarranz, ... Immunology and cell biology 88 (7), 734-745, 2010 | 63 | 2010 |
| CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts B Santiago, E Calonge, MJ Del Rey, I Gutierrez-Cañas, E Izquierdo, ... Cytokine 53 (2), 184-190, 2011 | 59 | 2011 |
| Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics RP Gomariz, I Gutierrez-Canas, A Arranz, M Carrion, Y Juarranz, J Leceta, ... Current Pharmaceutical Design 16 (9), 1063-1080, 2010 | 59 | 2010 |
| Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K I Gutiérrez‐Cañas, MG Juarranz, B Collado, N Rodríguez‐Henche, ... The Prostate 63 (1), 44-55, 2005 | 58 | 2005 |
| Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells B Collado, I Gutiérrez-Cañas, N Rodrı́guez-Henche, JC Prieto, ... Regulatory peptides 119 (1-2), 69-75, 2004 | 58 | 2004 |
| VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts A Arranz, I Gutiérrez-Cañas, M Carrión, Y Juarranz, JL Pablos, C Martínez, ... Molecular immunology 45 (11), 3065-3073, 2008 | 56 | 2008 |
| Profile of matrix-remodeling proteinases in osteoarthritis: impact of fibronectin S Pérez-García, M Carrión, I Gutiérrez-Cañas, R Villanueva-Romero, ... Cells 9 (1), 40, 2019 | 55 | 2019 |
| Regulation of TLR expression, a new perspective for the role of VIP in immunity RP Gomariz, A Arranz, Y Juarranz, I Gutierrez-Canas, M Garcia-Gomez, ... Peptides 28 (9), 1825-1832, 2007 | 51 | 2007 |
| A clinical approach for the use of VIP axis in inflammatory and autoimmune diseases C Martínez, Y Juarranz, I Gutiérrez-Cañas, M Carrión, S Pérez-García, ... International Journal of Molecular Sciences 21 (1), 65, 2019 | 50 | 2019 |
| Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors MG Juarranz, O Bolaños, I Gutiérrez-Cañas, EA Lerner, P Robberecht, ... Cellular signalling 13 (12), 887-894, 2001 | 49 | 2001 |
| The anti-inflammatory mediator, vasoactive intestinal peptide, modulates the differentiation and function of Th subsets in rheumatoid arthritis R Villanueva-Romero, I Gutiérrez-Cañas, M Carrión, S Pérez-García, ... Journal of Immunology Research 2018, 2018 | 47 | 2018 |
Juarranz Y or Juarranz MGCatedrática de Universidad, UCMVerified email at ucm.es
